SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-333663
Filing Date
2017-11-06
Accepted
2017-11-06 08:46:24
Documents
45
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d458566d10q.htm 10-Q 497743
2 EX-31.1 d458566dex311.htm EX-31.1 10200
3 EX-31.2 d458566dex312.htm EX-31.2 10437
4 EX-32.1 d458566dex321.htm EX-32.1 5857
  Complete submission text file 0001193125-17-333663.txt   3480831

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hrtx-20170930.xml EX-101.INS 807185
6 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20170930.xsd EX-101.SCH 31705
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20170930_cal.xml EX-101.CAL 28109
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20170930_def.xml EX-101.DEF 240631
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20170930_lab.xml EX-101.LAB 223015
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20170930_pre.xml EX-101.PRE 252744
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 171178380
SIC: 2834 Pharmaceutical Preparations